Recent studies have demonstrated that immunostaining for KRT7 and 20 can effectively differentiate primary ovarian carcinomas from metastatic carcinomas originating from the gastrointestinal tract and pancreas, which clinically resemble primary ovarian carcinoma (83). This evidence concerns the gene KRT7 and metastatic carcinoma.